Arthrex appeals Smith & Nephew patent loss; CytoSorbents teams with Biocon;

@FierceMedDev: Foundation Medicine eyes $92M in IPO. ICYMI Friday | Follow @FierceMedDev

@DamianFierce: Columbia Labs is buying into the CRO biz for $25M, grabbing Molecular Profiles. More from FierceCRO | Follow @DamianFierce

@MarkHFierce: Touch may help prevent hacking of insulin pumps and other wireless, implanted devices. Article via MIT Technology Review. | Follow @MarkHFierce

@MichaelGFierce: Delcath's chemo delivery device suffers FDA rejection. ICYMI from FierceDrugDelivery | Follow @MichaelGFierce

> Arthrex wants the U.S. Supreme Court to hear an appeal of its $85 million patent infringement loss to Smith & Nephew ($SNN). Story

> Corindus Vascular Robotics has started a study testing the safety and effectiveness of robotic angioplasty procedures. Item

> Stent developer InspireMD brought on a new head of global marketing and strategy. Item

> CytoSorbents will link with Biocon to bring its blood purification device to India. Story

Biotech News

@FierceBiotech: Veeva, provider of sales software to Merck, seeks up to $150M in IPO. Story from FierceBiotech IT | Follow @FierceBiotech

@JohnCFierce: ICYMI: ViroPharma shares soar on report of possible buyout offer. Article | Follow @JohnCFierce

@EmilyMFierce: Cheaper sequencing points cancer drug researchers to 'super responders.' More | Follow @EmilyMFierce

> Biosimilars developer Celltrion defends against allegations of insider trading. Report

> NovaBay shares jump on positive PhII catheter solution study. Item

> Chiesi values Cornerstone Therapeutics at $255M in buyout deal. Story

> FDA lifts hold on Pluristem's stem cell trial after tweaking protocol. News

Pharma News

@FiercePharma: GSK's happy: Arzerra won FDA breakthrough status; now, priority review for melanoma combo Tafinlar + Mekinist. Article | Follow @FiercePharma

@EricPFierce: GSK, Genmab get FDA 'breakthrough' designation for Arzerra in first-line use. ICYMI Friday | Follow @EricPFierce

@CarlyHFierce: Check out the new report by @EricPFierce: Top 10 rheumatoid arthritis drugs 2013. Feature | Follow @CarlyHFierce

> Roche lands Lufthansa CEO to take over chairman's job. News

> New Ranbaxy import ban provides Novartis with unexpected benefit. Story

> Viehbacher: Sanofi's options include buying back stake from L'Oreal, upping stake in Regeneron. Article

CRO News

> Harlan ups its European presence. Item

> Theorem teams with Charles River on preclinical work. Report

> Indian CRO TCG teams with Debiopharm for antibiotics. More

> Bayer taps DKSH with eye on Singapore. Story

> Italy's CROS NT reaches into U.S. with Stat-Tech buyout. Article

Biotech IT News

> TranSMART releases new version of research software from Johnson & Johnson. Item

> Qlucore corrals EU funding for hepatitis C software. Report

> AstraZeneca supports iPhone app for helping patients with heart disease. Article

> MIT center grabs $25M grant to build human-like computers. More

> Treato releases latest software: not another social media-listening app for pharma? Story

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.